BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31963684)

  • 1. The Preparation of Ginsenoside Rg5, Its Antitumor Activity against Breast Cancer Cells and Its Targeting of PI3K.
    Liu Y; Fan D
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
    Liu Y; Fan D
    Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rg5 induces NSCLC cell apoptosis and autophagy through PI3K/Akt/mTOR signaling pathway.
    Zhang C; Jin Y
    Hum Exp Toxicol; 2024; 43():9603271241229140. PubMed ID: 38289222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg5 induces apoptosis in human esophageal cancer cells through the phosphoinositide‑3 kinase/protein kinase B signaling pathway.
    Zhang D; Wang A; Feng J; Zhang Q; Liu L; Ren H
    Mol Med Rep; 2019 May; 19(5):4019-4026. PubMed ID: 30942438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg5 Inhibits Human Osteosarcoma Cell Proliferation and Induces Cell Apoptosis through PI3K/Akt/mTORC1-Related LC3 Autophagy Pathway.
    Liu MY; Liu F; Li YJ; Yin JN; Gao YL; Wang XY; Yang C; Liu JG; Li HJ
    Oxid Med Cell Longev; 2021; 2021():5040326. PubMed ID: 34257801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
    Yu X; Wang Q; Dai Z
    J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
    Liu Y; Fan D
    Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells.
    Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J
    Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside-Rg5 Inhibits Retinoblastoma Proliferation and Induces Apoptosis through Suppressing BCL2 Expression.
    Cui Y; Su Y; Deng L; Wang W
    Chemotherapy; 2018; 63(5):293-300. PubMed ID: 30731458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
    Liu H; Zhao J; Fu R; Zhu C; Fan D
    PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway.
    Li W; Li G; She W; Hu X; Wu X
    J BUON; 2019; 24(5):2056-2061. PubMed ID: 31786875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway.
    Nan F; Sun G; Xie W; Ye T; Sun X; Zhou P; Dong X; Sun J; Sun X; Zhang M
    Mol Cell Probes; 2019 Dec; 48():101469. PubMed ID: 31629029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells.
    Chen C; Lv Q; Li Y; Jin YH
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34199025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
    Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
    Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell.
    Xie Q; Wen H; Zhang Q; Zhou W; Lin X; Xie D; Liu Y
    Biomed Pharmacother; 2017 Jan; 85():16-21. PubMed ID: 27930981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg5 attenuates hypoxia-induced cardiomyocyte apoptosis via regulating the Akt pathway.
    Wang C; Huang C; Wang J; Ye J; Xue Z; Zhang J; Ren Y
    Chem Biol Drug Des; 2023 Jun; 101(6):1348-1355. PubMed ID: 36762503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway.
    Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z
    Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study.
    Jabbarzadeh Kaboli P; Leong MP; Ismail P; Ling KH
    Pharmacol Rep; 2019 Feb; 71(1):13-23. PubMed ID: 30343043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.